File Code: Public Health
- Sponsored By:
-
Delegates Boutin and Morhaim
- Entitled:
-
Prescription Drugs - Price Controls
Requiring the Health Services Cost Review Commission to regulate
prices at which pharmaceutical manufacturers may sell prescription
drugs; requiring the Commission to periodically participate in or do
analyses and studies that relate to prescription drug costs;
prohibiting the Commission from including the amount of a penalty in
the cost of a prescription drug for the purpose of regulating the
price of the drug; requiring a pharmaceutical manufacturer to provide
information and documents; etc.
House Action
- 1/28
- First Reading Health and Government Operations
- 2/2
- Hearing 2/15 at 1:00 p.m.
- 3/7
- Unfavorable Report by Health and Government Operations
Senate Action
- No Action
Sponsored by:
- Delegate Charles R. Boutin, District 34A
- Delegate Dan K. Morhaim, District 11
Bill indexed under the following Subjects:
- COMMITTEES AND COMMISSIONS -see also- POLITICAL COMMITTEES
- DISCLOSURE
- DRUGS -see also- CONTROLLED DANGEROUS SUB; SUBSTANCE ABUSE
- FEES -see also- DEVELOPMENT FEES AND TAXES
- HEALTH PLANNING AND COST REVIEW
- HEARINGS
- PENALTIES
- PRICES -see also- CONSUMER PRICE INDEX
- PRIVACY
- REPORTS
- RULES AND REGULATIONS
Bill affects the following Statutes:
- Health - General
- (
19-207 ,
19-230 ,
19-231 ,
19-232 ,
19-233 ,
19-234 ,
19-235 ,
19-236
)
- Bill Text (Displayed in PDF Format):
First Reading,
Third Reading, Enrolled
- Fiscal Note (Displayed in PDF Format):
Available
- Amendments:
None offered
